Plumbagin in Combination with Vemurafenib for BRAF-Mutant Melanoma

Grant

Date/time Interval

  • September 21, 2017 - August 31, 2019
  • Total Award Amount

  • 148500.00
  • Direct Costs

  • 100000.00
  • Sponsor Award Id

  • R03CA212798
  • Contributor

  • Farrukh Afaq Ph.D.   Principal Investigator